About: Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
Creator	Cai, Hui Steinmetz, Nicole Chung, Young Edu, Nsteinmetz@ucsd
topic	covid:1fda76a69438965caf81fe119b71e0c40d2400c5#this
Source	Elsevier; Medline; PMC
abstract	Viral nanoparticles (VNPs) encompass a diverse array of naturally occurring nanomaterials derived from plant viruses, bacteriophages, and mammalian viruses. The application and development of VNPs and their genome-free versions, the virus-like particles (VLPs), for nanomedicine is a rapidly growing. VLPs can encapsulate a wide range of active ingredients as well as be genetically or chemically conjugated to targeting ligands to achieve tissue specificity. VLPs are manufactured through scalable fermentation or molecular farming, and the materials are biocompatible and biodegradable. These properties have led to a wide range of applications, including cancer therapies, immunotherapies, vaccines, antimicrobial therapies, cardiovascular therapies, gene therapies, as well as imaging and theranostics. The use of VLPs as drug delivery agents is evolving, and sufficient research must continuously be undertaken to translate these therapies to the clinic. This review highlights some of the novel research efforts currently underway in the VNP drug delivery field in achieving this greater goal.
has issue date	2020-06-27(xsd:dateTime)
bibo:doi	10.1016/j.addr.2020.06.024
bibo:pmid	32603813
has license	no-cc
sha1sum (hex)	1fda76a69438965caf81fe119b71e0c40d2400c5
schema:url	https://doi.org/10.1016/j.addr.2020.06.024
resource representing a document's title	Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
has PubMed Central identifier	PMC7320870
has PubMed identifier	32603813
schema:publication	Adv Drug Deliv Rev
resource representing a document's body	covid:1fda76a69438965caf81fe119b71e0c40d2400c5#body_text
is http://vocab.deri.ie/void#inDataset of	proxy:http/ns.inria.fr/covid19/1fda76a69438965caf81fe119b71e0c40d2400c5
is schema:about of	named entity 'array' named entity 'immunotherapy' named entity 'tumor' named entity 'traditional methods' named entity 'tumor' named entity 'Asp' named entity 'VLPs' named entity 'lungs' named entity 'fluorescent' named entity 'antibody' named entity 'macrophages' named entity 'germline' named entity 'Tyr' named entity 'dye' named entity 'phosphorylated' named entity 'epitopes' named entity 'tumor' named entity 'ligand' named entity 'VLP' named entity 'infection' named entity 'anticoagulant drug' named entity 'enterovirus 71' named entity 'ORCAs' named entity 'nanotechnology' named entity 'conjugated' named entity 'targeted delivery' named entity 'vaccine' named entity 'laser' named entity 'methanol' named entity 'conjugation' named entity 'Food and Drug Administration' named entity 'nanomaterial' named entity 'tPA' named entity 'MRI imaging' named entity 'conjugated' named entity 'VLPs' named entity 'bioconjugation' named entity 'virus capsids' named entity 'PET' named entity 'HPV' named entity 'virus' named entity 'PET' named entity 'antitumor' named entity 'protein' named entity 'passive diffusion' named entity 'radiation therapy' named entity 'coat protein' named entity 'HeLa' named entity 'protein' named entity 'antigens' named entity 'conjugation' named entity 'transaminated' named entity 'Env' named entity 'signal-to-noise ratio' named entity 'antigens' named entity 'conjugation' named entity 'tauopathy' named entity 'nontoxic' named entity 'mannose' named entity 'epitope' named entity 'self-assembly' named entity 'therapeutic modalities' named entity 'complement' named entity 'galectin' named entity 'epitope' named entity 'nucleic acid' named entity 'bacteriophage' named entity 'platinum-based anticancer drugs' named entity 'radiation therapy' named entity 'chemotherapy' named entity 'nanoparticle' named entity 'drug clearance' named entity 'amyloid precursor protein' named entity 'test tube' named entity 'PDA' named entity 'viruses'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software